Anti-tumor effect of lentivirus-mediated gene transfer of alphastatin on human glioma

Cancer Science

Volumn 102, Issue 5, 2011, Pages 1038-1044

  Guo, Shi Wen ^a   Che, Hong Min ^a   Li, Wen Zhi ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHASTATIN; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; LENTIVIRUS VECTOR; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GENE EXPRESSION SYSTEM; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; UMBILICAL VEIN; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; FIBRINOGEN; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LENTIVIRUS; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79954937161     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01879.x     Document Type: Article

References (41)

1. Brem S, Tsanaclis AM, Gately S et al. Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer 1992; 70: 2673-80.
2. Plate KH, Risau W. Angiogenesis in malignant gliomas. Glia 1995; 15: 339-47.
3. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996; 77: 362-72.
4. Staton CA, Brown NJ, Rodgers GR et al. Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo. Blood 2004; 103: 601-6.
5. Chen L, Li T, Li R et al. Alphastatin downregulates vascular endothelial cells sphingosine kinase activity and suppresses tumor growth in nude mice bearing human gastric cancer xenografts. World J Gastroenterol 2006; 12: 4130-6.
6. Staton CA, Stribbling SM, Garcia-Echeverria C et al. Identification of key residues involved in mediating the in vivo anti-tumor/anti-endothelial activity of Alphastatin. J Thromb Haemost 2007; 5: 846-54.
7. Shichinohe T, Bochner BH, Mizutani K et al. Development of lentiviral vectors for antiangiogenic gene delivery. Cancer Gene Ther 2001; 8: 879-89.
8. Folkman J. Antiangiogenic gene therapy. Proc Natl Acad Sci U S A 1998; 95: 9064-6.
9. Kong HL, Crystal RG. Gene therapy strategies for tumor antiangiogenesis. J Natl Cancer Inst 1998; 90: 273-86.
10. Naldini L, Blomer U, Gage FH et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 1996; 93: 11382-8.
11. Zufferey R, Nagy D, Mandel RJ et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871-5.
12. Jaffe EA, Nachman RL, Becker CG et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-56.
13. Song LP, Li YP, Wang N et al. NT4(Si)-p53(N15)-antennapedia induces cell death in a human hepatocellular carcinoma cell line. World J Gastroenterol 2009; 15: 5813-20.
14. Xiaojiang T, Jinsong Z, Jiansheng W et al. Adeno-associated virus harboring fusion gene NT4-ant-shepherdin induce cell death in human lung cancer cells. Cancer Invest 2010; 28: 465-71.
15. Li Y, Qiu S, Song L et al. Secretory expression of p53(N15)-Ant following lentivirus-mediated gene transfer induces cell death in human cancer cells. Cancer Invest 2008; 26: 28-34.
16. Marr RA, Rockenstein E, Mukherjee A et al. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci 2003; 23: 1992-6.
17. Liu J, Kolath J, Anderson J et al. Positive interaction between 5-FU and FdUMP[10] in the inhibition of human colorectal tumor cell proliferation. Antisense Nucleic Acid Drug Dev 1999; 9: 481-6.
18. Malinda KM, Ponce L, Kleinman HK et al. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res 1999; 250: 168-73.
19. Grosios K, Holwell SE, McGown AT et al. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug. Br J Cancer 1999; 81: 1318-27.
20. Beckstead JH. A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues. J Histochem Cytochem 1994; 42: 1127-34.
21. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25: 581-611.
22. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-64.
23. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001; 49: 507-21.
24. Naldini L, Blomer U, Gallay P et al. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 1996; 272: 263-7.
25. Zufferey R, Dull T, Mandel RJ et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72: 9873-80.
26. Schlegel R, Tralka TS, Willingham MC et al. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 1983; 32: 639-46.
27. Nagai K, Oubridge C, Kuglstatter A et al. Structure, function and evolution of the signal recognition particle. EMBO J 2003; 22: 3479-85.
28. Muller JP, Bron S, Venema G et al. Chaperone-like activities of the CsaA protein of bacillus subtilis. Microbiology 2000; 146: 77-88.
29. Tjalsma H, Antelmann H, Jongbloed JD et al. Proteomics of protein secretion by bacillus subtilis: separating the "secrets" of the secretome. Microbiol Mol Biol Rev 2004; 68: 207-33.
30. Zanen G, Antelmann H, Meima R et al. Proteomic dissection of potential signal recognition particle dependence in protein secretion by bacillus subtilis. Proteomics 2006; 6: 3636-48.
31. Fan G, Egles C, Sun Y et al. Knocking the NT4 gene into the BDNF locus rescues BDNF deficient mice and reveals distinct NT4 and BDNF activities. Nat Neurosci 2000; 3: 350-7.
32. Sim BK, MacDonald NJ, Gubish ER. Angiostatin and endostatin: endogenous inhibitors of tumor growth. Cancer Metastasis Rev 2000; 19: 181-90.
33. Bouck N. Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells 1990; 2: 179-85.
34. Kanno S, Oda N, Abe M et al. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene 2000; 19: 2138-46.
35. Rousseau S, Houle F, Kotanides H et al. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J Biol Chem 2000; 275: 10661-72.
36. Lamalice L, Houle F, Jourdan G et al. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Oncogene 2004; 23: 434-45.
37. Meadows KN, Bryant P, Vincent PA et al. Activated Ras induces a proangiogenic phenotype in primary endothelial cells. Oncogene 2004; 23: 192-200.
38. Louis DN, Pomeroy SL, Cairncross JG. Focus on central nervous system neoplasia. Cancer Cell 2002; 1: 125-8.
39. Papale A, Cerovic M, Brambilla R. Viral vector approaches to modify gene expression in the brain. J Neurosci Methods 2009; 185: 1-14.
40. Liu Y, Deisseroth A. Tumor vascular targeting therapy with viral vectors. Blood 2006; 107: 3027-33.
41. Calabrese C, Poppleton H, Kocak M et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007; 11: 69-82.